Letter to the Editor prevalence is at least 20%, but it is not applicable to Helicobacter pylori among patients with patients with alarm symptoms . Economic models uninvestigated dyspepsia: issues to be suggest that in areas with less than 20% H. pylori pre- remembered valence, the test-and-treat approach may not be cost effective . However, what can we expect from H. pylori a b a Rinaldo Pellicano and Marilena Durazzo , Unit of Gastroenterology, eradication? Department of Gastroenterology and Hepatology, Molinette Hospital and Department of Medical Sciences, University of Turin, Turin, Italy Although worldwide data are heterogeneous, both in terms of prevalence and posteradication beneﬁt, the Correspondence to Rinaldo Pellicano, MD, Department of Gastroenterology and European guidelines state that bacterial cure produces long- Hepatology, Molinette Hospital, Via Cavour 31, Turin 10126, Italy term beneﬁts in one of 12 patients with H. pylori infection Tel: + 39 11 6333565; fax: + 39 11 6336249; and functional dyspepsia, and that this is better than any e-mail: email@example.com other treatment . Hence, treating this bacterium is easy Received 18 November 2017 Accepted 5 December 2017 and cheap but with deluding long-term beneﬁts. For this reason, several systematic reviews consider proton pump inhibitor
European Journal of Gastroenterology & Hepatology – Wolters Kluwer Health
Published: Mar 1, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
It’s easy to organize your research with our built-in tools.
All the latest content is available, no embargo periods.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud